Forgue M E, Freychet P
Diabetes. 1975 Aug;24(8):715-23. doi: 10.2337/diab.24.8.715.
The presence of insulin receptors in the heart muscle was investigated by measuring the binding of 125I-insulin to specific subcellular fractions of the rat and mouse myocardium. 125I-insulin bound to the plasma membrane fraction with a high degree of specificity and affinity. Insulin analogues competed with 125I-insulin in direct proportion to their biologic potency in vitro. Unlabeled insulin within the range of its concentrations in vivo inhibited 15 to 60 per cent of the 125I-insulin binding. The specific binding sites were finite in number and represented about 90 per cent of the total binding. The insulin-binding capacity of the plasma membrane fraction was twelve- to fifteenfold higher than that of the mitochondrial fraction. As in the liver, the binding was time- and temperature-dependent with a slower but higher binding achieved at a lower temperature. The binding sites appeared to be heterogeneous with respect to affinity. At 5 degrees C., the "higher-affinity" site had a K of about 2 times 10(9) M-1. No more than 10 per cent of the 125I-insulin was degraded by the heart plasma membranes after one hour at 30 degrees C. or twenty-two hours at 5 degrees C. Studies in the obese hyperglycemic (ob/ob) mouse revealed that the insulin binding is impaired in the heart muscle of this animal. Over a wide range of insulin concentrations, the plasma membrane fraction of ob/ob mice bound only 25 to 40 per cent as much insulin as did membranes of the thin littermates, suggesting that, as in the liver, the fat tissue, and the thymic lymphocyte, the number of insulin-binding sites is decreased in the heart of the ob/ob mouse. This defect selectively affected the plasma membrane fraction and could not be explained by differences in membrane purification or insulin-degrading activity. Heart and liver membranes of forty-hour fasted ob/ob mice bound two to three times as much insulin as did membranes of ob/ob mice fed ad libitum. These studies demonstrate and characterize the binding of insulin to heart muscle membranes; they extend to the heart muscle the insulin receptor defect also found in liver membranes and cells, in fat cell membranes, and in thymic lymphocytes of the ob/ob mouse.
通过测量¹²⁵I - 胰岛素与大鼠和小鼠心肌特定亚细胞组分的结合,对心肌中胰岛素受体的存在情况进行了研究。¹²⁵I - 胰岛素以高度的特异性和亲和力与质膜组分结合。胰岛素类似物与¹²⁵I - 胰岛素竞争,其竞争程度与它们在体外的生物活性成正比。体内浓度范围内的未标记胰岛素抑制了15%至60%的¹²⁵I - 胰岛素结合。特异性结合位点数量有限,约占总结合量的90%。质膜组分的胰岛素结合能力比线粒体组分高12至15倍。与肝脏一样,这种结合具有时间和温度依赖性,在较低温度下结合较慢但较高。结合位点在亲和力方面似乎是异质性的。在5℃时,“高亲和力”位点的K约为2×10⁹M⁻¹。在30℃下1小时或5℃下22小时后,心脏质膜降解的¹²⁵I - 胰岛素不超过10%。对肥胖高血糖(ob/ob)小鼠的研究表明,该动物心肌中的胰岛素结合受损。在很宽的胰岛素浓度范围内,ob/ob小鼠的质膜组分结合的胰岛素仅为瘦同窝小鼠膜结合量的25%至40%,这表明,与肝脏、脂肪组织和胸腺淋巴细胞一样,ob/ob小鼠心脏中胰岛素结合位点的数量减少。这种缺陷选择性地影响质膜组分,不能用膜纯化或胰岛素降解活性的差异来解释。禁食40小时的ob/ob小鼠的心脏和肝脏膜结合的胰岛素是自由进食的ob/ob小鼠膜结合量的两到三倍。这些研究证明并描述了胰岛素与心肌膜的结合;它们将在ob/ob小鼠的肝膜和细胞、脂肪细胞膜以及胸腺淋巴细胞中也发现的胰岛素受体缺陷扩展到了心肌。